The use of bivalent COVID-19 vaccines that target both the original COVID-19 virus and Omicron sub-variants, has been expanded to include children aged 6 months to 5 years by the US CDC. The expansion comes a day after the US Food and Drug Administration (FDA) approved the bilvalent COVID-19 vaccine shots developed by Pfizer/BioNTech as […]
Continue Reading
The UK Medicines and Healthcare products Regulatory Agency (MHRA) has approved the Pfizer and BioNTech COVID-19 vaccine for use in children and infants aged 6 months to 4 years. The UK MHRA has authorized the vaccine in the new age group after the agency found to meet the standards of safety, effectiveness, and quality, with […]
Continue Reading
Pfizer and its German partner BioNTech are asking the US Food and Drug Administration (FDA) to approve the new COVID-19 booster vaccine shots targeting the Omicron variant for school-age children. Pfizer and BioNTech submitted an application for emergency use authorization of their BA.4 and BA.5 focused bivalent vaccines for children between 5 to 11 years […]
Continue Reading
Moderna said it is suing Pfizer and BioNTech for patent infringement linked to the development of the first COVID-19 vaccines. The biotech company based in the United States is alleging that mRNA technology, which Moderna developed before the COVID-19 pandemic, was copied. The lawsuit, which is seeking unspecified financial damages, was filed in the United […]
Continue Reading
Pfizer Inc. and BioNTech announced they have completed a submission to the US Food and Drug Administration (FDA) requesting Emergency Use Authorization (EUA) of a booster dose of an Omicron adapted bivalent COVID-19 vaccine for individuals over 12 years. This application follows guidance from the US FDA to include clinical data from the bivalent Omicron […]
Continue Reading
Pfizer and BioNTech has now asked the regulators of the United States for the purpose of authorizing an additional booster dose of the company’s novel corona virus vaccine for the seniors saying that, the data from Israel has been suggesting the senior or old adults is going to be benefited. Currently, the government of the […]
Continue Reading
On Thursday, 16th December 2021, the US CDC has recommended to the people of the United States for choosing to receive one of the two other authorized novel corona virus vaccines over the covid-19 vaccine shot developed by Johnson and Johnson because of the rare and fatal cases of the blood-clotting. This move comes after […]
Continue Reading
According to a new study led by the researchers of United Kingdom at University of Oxford has found that, the protection against the new and highly contagious Delta variant of corona virus from the covid-19 vaccines developed by Pfizer/BioNTech and AstraZeneca weakens with three months after receiving both the doses of the vaccines. The two […]
Continue Reading
Pfizer and BioNTech have announced, they have submitted the data of the phase 1 trials of the vaccine to the US FDA for the purpose of supporting the evaluation of a third dose or the booster dose of the novel corona virus vaccine for getting the license in the future, and the data of these […]
Continue Reading
On Monday, 26th July 2021, the drugmaker ‘BioNTech’ of Germany has announced the plans for the purpose of developing a vaccine, which is going to be based on the mRNA technology for the prevention of the Malaria Disease, which is also a life-threatening disease, that impacts millions of the people across the world each year. […]
Continue Reading